Immunoproteasomes: structure, function, and antigen presentation.

[1]  C. Harding.  Faculty Opinions recommendation of Mice completely lacking immunoproteasomes show major changes in antigen presentation. , 2012 .

[2]  A. Paller,et al.  Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. , 2012, Arthritis and rheumatism.

[3]  M. Groettrup,et al.  The Antiviral Immune Response in Mice Devoid of Immunoproteasome Activity , 2011, The Journal of Immunology.

[4]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[5]  Wooin Lee,et al.  The immunoproteasome: an emerging therapeutic target. , 2011, Current topics in medicinal chemistry.

[6]  D. Standley,et al.  A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. , 2011, The Journal of clinical investigation.

[7]  P. Kloetzel,et al.  Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus Myocarditis , 2011, PLoS pathogens.

[8]  B. Lie,et al.  Proteasome Immunosubunits Protect against the Development of CD8 T Cell-Mediated Autoimmune Diseases , 2011, The Journal of Immunology.

[9]  C. Boog,et al.  Immunoproteasome-Deficiency Has No Effects on NK Cell Education, but Confers Lymphocytes into Targets for NK Cells in Infected Wild-Type Mice , 2011, PloS one.

[10]  N. Niikawa,et al.  Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome , 2011, Proceedings of the National Academy of Sciences.

[11]  P. Kloetzel,et al.  PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I‐binding peptides in vivo , 2011, European journal of immunology.

[12]  C. Papasian,et al.  The Immunoproteasomes Regulate LPS-Induced TRIF/TRAM Signaling Pathway in Murine Macrophages , 2011, Cell Biochemistry and Biophysics.

[13]  S. Tonegawa,et al.  Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma , 2011, Sarcoma.

[14]  D. Ferrington,et al.  A novel role for the immunoproteasome in retinal function. , 2011, Investigative ophthalmology & visual science.

[15]  D. Chauhan,et al.  PR‐924, a selective inhibitor of the immunoproteasome subunit LMP‐7, blocks multiple myeloma cell growth both in vitro and in vivo , 2011, British journal of haematology.

[16]  B. J. Van den Eynde,et al.  Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome , 2011, European journal of immunology.

[17]  A. Garg,et al.  PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. , 2010, American journal of human genetics.

[18]  B. J. Van den Eynde,et al.  Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules , 2010, Proceedings of the National Academy of Sciences.

[19]  Jennifer L. Muzyka,et al.  Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations. , 2010, The journal of physical chemistry. B.

[20]  A. Garg,et al.  An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy. , 2010, The Journal of clinical endocrinology and metabolism.

[21]  P. Kloetzel,et al.  Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.

[22]  M. Groettrup,et al.  Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome , 2010, The Journal of Immunology.

[23]  L. Becker,et al.  Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice. , 2010, Journal of molecular and cellular cardiology.

[24]  H. Mollenkopf,et al.  Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis , 2010, Gut.

[25]  D. Ferrington,et al.  Immunoproteasome deficiency alters retinal proteasome’s response to stress , 2010, Journal of neurochemistry.

[26]  Sébastien Lemieux,et al.  Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules* , 2010, Molecular & Cellular Proteomics.

[27]  J. Yewdell,et al.  Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses , 2010, The Journal of Immunology.

[28]  Sandra D'Alfonso,et al.  Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population , 2010, PloS one.

[29]  Keiji Tanaka,et al.  Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection , 2009, European Journal of Immunology.

[30]  Khalid W. Kalim,et al.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.

[31]  D. Kuhn,et al.  Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors. , 2009, Blood.

[32]  R. Dohmen,et al.  Catalytic mechanism and assembly of the proteasome. , 2009, Chemical reviews.

[33]  D. Ruano,et al.  Age‐related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects , 2009, Journal of neurochemistry.

[34]  L. Becker,et al.  Ischemic preconditioning‐induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide‐2 deficiency , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Jie Du,et al.  Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. , 2008, Endocrinology.

[36]  J. Drijfhout,et al.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. , 2008, The Journal of clinical investigation.

[37]  D. Ferrington,et al.  Immunoproteasome responds to injury in the retina and brain , 2008, Journal of neurochemistry.

[38]  Keiji Tanaka,et al.  Thymoproteasome: probable role in generating positively selecting peptides. , 2008, Current opinion in immunology.

[39]  Kenta Okamoto,et al.  Crystal structure of a chaperone complex that contributes to the assembly of yeast 20S proteasomes , 2008, Nature Structural &Molecular Biology.

[40]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[41]  Peipei Ping,et al.  Mammalian Proteasome Subpopulations with Distinct Molecular Compositions and Proteolytic Activities* , 2007, Molecular & Cellular Proteomics.

[42]  Peter R Jungblut,et al.  Intermediate-type 20 S proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. , 2007, Journal of molecular biology.

[43]  J. McCabe,et al.  Alterations of cerebral cortex and hippocampal proteasome subunit expression and function in a traumatic brain injury rat model , 2007, Journal of neurochemistry.

[44]  M. Groll,et al.  Diversity of proteasomal missions: fine tuning of the immune response , 2007, Biological chemistry.

[45]  T. Illig,et al.  Strong associations of psoriasis with antigen processing LMP and transport genes TAP differ by gender and phenotype , 2007, Genes and Immunity.

[46]  Keiji Tanaka,et al.  Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes , 2007, Science.

[47]  P. Kloetzel,et al.  The N-terminal Flanking Region of the TRP2360–368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation* , 2007, Journal of Biological Chemistry.

[48]  D. Ferrington,et al.  Age-dependent inhibition of proteasome chymotrypsin-like activity in the retina. , 2007, Experimental eye research.

[49]  C. Reilly,et al.  Transformation of the proteasome with age‐related macular degeneration , 2007, FEBS letters.

[50]  M. Dolz,et al.  CD8+ T-Cell Responses Identify β-Cell Autoimmunity in Human Type 1 Diabetes , 2007, Diabetes.

[51]  K. Lew,et al.  RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing. , 2006, Investigative ophthalmology & visual science.

[52]  C. Loddenkemper,et al.  Proteasome-mediated degradation of IκBα and processing of p105 in Crohn disease and ulcerative colitis , 2006 .

[53]  P. Kloetzel,et al.  Immunoproteasomes Are Essential for Clearance of Listeria monocytogenes in Nonlymphoid Tissues but Not for Induction of Bacteria-Specific CD8+ T Cells1 , 2006, The Journal of Immunology.

[54]  M. Groettrup,et al.  An Altered T Cell Repertoire in MECL-1-Deficient Mice1 , 2006, The Journal of Immunology.

[55]  P. Kloetzel,et al.  A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms , 2006, Biological chemistry.

[56]  D. Busch,et al.  Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Matalon,et al.  Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. , 2006, Free radical biology & medicine.

[58]  A. Bruce-Keller,et al.  LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. , 2006, Antioxidants & redox signaling.

[59]  Tilman Grune,et al.  Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains , 2006, Neurobiology of Aging.

[60]  B. Monsarrat,et al.  Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation1 , 2006, The Journal of Immunology.

[61]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[62]  Tohru Natsume,et al.  A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes , 2005, Nature.

[63]  P. Kloetzel,et al.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Yewdell,et al.  Immunoproteasomes: regulating the regulator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Ferrington,et al.  Altered proteasome structure, function, and oxidation in aged muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  J. Granados,et al.  Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. , 2004, Human immunology.

[67]  K. Davies,et al.  Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis. , 2004, Archives of biochemistry and biophysics.

[68]  Isidro Ferrer,et al.  Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.

[69]  Vidya N. Nukala,et al.  Role of the proteasome in protein oxidation and neural viability following low‐level oxidative stress , 2003, FEBS letters.

[70]  B. Dahlmann,et al.  Alteration of 20S proteasome-subtypes and proteasome activator PA28 in skeletal muscle of rat after induction of diabetes mellitus. , 2003, The international journal of biochemistry & cell biology.

[71]  J. Monaco,et al.  β2 Subunit Propeptides Influence Cooperative Proteasome Assembly* , 2003, The Journal of Biological Chemistry.

[72]  D. Schadendorf,et al.  The role of the proteasome activator PA28 in MHC class I antigen processing. , 2002, Molecular immunology.

[73]  Xianglin Shi,et al.  Upstream signal transduction of NF-kappaB activation. , 2002, Current drug targets. Inflammation and allergy.

[74]  D. Schadendorf,et al.  Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. , 2002, Cancer research.

[75]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[76]  S. Jentsch,et al.  Taking a bite: proteasomal protein processing , 2002, Nature Cell Biology.

[77]  A. Bruce-Keller,et al.  Polyglutamine Expansion, Protein Aggregation, Proteasome Activity, and Neural Survival* , 2002, The Journal of Biological Chemistry.

[78]  K. Schwarz,et al.  Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver1 , 2001, The Journal of Immunology.

[79]  T. Hayashi,et al.  Selected contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis. , 2001, Journal of applied physiology.

[80]  Jonathan W. Yewdell,et al.  Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens , 2001, The Journal of experimental medicine.

[81]  K. Davies.  Degradation of oxidized proteins by the 20S proteasome. , 2001, Biochimie.

[82]  A. Rivett,et al.  gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. , 2001, The Biochemical journal.

[83]  P M Kloetzel,et al.  Different proteasome subtypes in a single tissue exhibit different enzymatic properties. , 2000, Journal of molecular biology.

[84]  H. Ploegh,et al.  LMP2 expression and proteasome activity in NOD mice , 2000, Nature Medicine.

[85]  Ferry Ossendorp,et al.  Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28 , 2000, The Journal of experimental medicine.

[86]  G. Stark,et al.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.

[87]  Takuma Hayashi,et al.  Essential Role of Human Leukocyte Antigen-encoded Proteasome Subunits in NF-κB Activation and Prevention of Tumor Necrosis Factor-α-induced Apoptosis* , 2000, The Journal of Biological Chemistry.

[88]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[89]  Takuma Hayashi,et al.  NOD Mice Are Defective in Proteasome Production and Activation of NF-κB , 1999, Molecular and Cellular Biology.

[90]  A. Goldberg,et al.  Proteolysis and class I major histocompatibility complex antigen presentation , 1999, Immunological reviews.

[91]  T. Reinheckel,et al.  Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.

[92]  R. Kohanski,et al.  Altered Properties of the Branched Chain Amino Acid-preferring Activity Contribute to Increased Cleavages after Branched Chain Residues by the “Immunoproteasome”* , 1998, The Journal of Biological Chemistry.

[93]  L. Kaer,et al.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. , 1998 .

[94]  T. Smolarek,et al.  DNA sequence, chromosomal localization, and tissue expression of the mouse proteasome subunit lmp10 (Psmb10) gene. , 1997, Genomics.

[95]  M. Kasahara,et al.  The mouse genes encoding the third pair of beta-type proteasome subunits regulated reciprocally by IFN-gamma: structural comparison, chromosomal localization, and analysis of the promoter. , 1997, Journal of immunology.

[96]  P. Kloetzel,et al.  The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[97]  M. Bevan,et al.  Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. , 1997, Blood.

[98]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[99]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[100]  J. Monaco,et al.  Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit. , 1996, Journal of immunology.

[101]  K. Tanaka,et al.  Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma , 1996, The Journal of experimental medicine.

[102]  P. Kloetzel,et al.  A third interferon‐γ‐induced subunit exchange in the 20S proteasome , 1996, European journal of immunology.

[103]  S. Beck,et al.  Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter , 1995, The Journal of experimental medicine.

[104]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[105]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[106]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[107]  C. Milstein,et al.  Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[108]  P. Zhou,et al.  Genomic organization and tissue expression of the mouse proteasome gene Lmp-7 , 1993, Immunogenetics.

[109]  P. Zhou,et al.  Genomic organization and tissue expression of mouse proteasome gene Lmp-2. , 1993, Genomics.

[110]  P. A. Peterson,et al.  Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. , 1992, The Journal of biological chemistry.

[111]  P. A. Peterson,et al.  Proteasomes are regulated by interferon gamma: implications for antigen processing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Günter J. Hämmerling,et al.  Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex , 1991, Nature.

[113]  S. Beck,et al.  Second proteasome-related gene in the human MHC class II region , 1991, Nature.

[114]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[115]  J. Monaco,et al.  Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.

[116]  Timothy E. Elliott,et al.  The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.

[117]  H. Mcdevitt,et al.  The LMP antigens: a stable MHC-controlled multisubunit protein complex. , 1986, Human immunology.

[118]  A. Hershko,et al.  A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. , 1978, Biochemical and biophysical research communications.

[119]  M. Groettrup,et al.  Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.

[120]  J. Lucas,et al.  Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtin , 2009, Neurotoxicity Research.

[121]  K. Borowicz,et al.  Role of nuclear factor kappaB in the central nervous system. , 2007, Pharmacological reports : PR.

[122]  B. Morris,et al.  Regulation of the Neuronal Proteasome by Zif268 (Egr1) , 2006, The Journal of Neuroscience.

[123]  D. Ferrington,et al.  Altered proteasome function and subunit composition in aged muscle. , 2004, Archives of biochemistry and biophysics.

[124]  J. Monaco,et al.  Beta 2 subunit propeptides influence cooperative proteasome assembly. , 2003, The Journal of biological chemistry.

[125]  A. Goldberg,et al.  Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.

[126]  M. Probst-Kepper,et al.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. , 2000, Immunity.

[127]  T. Hayashi,et al.  Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. , 2000, The Journal of biological chemistry.

[128]  T. Hayashi,et al.  NOD mice are defective in proteasome production and activation of NF-kappaB. , 1999, Molecular and cellular biology.

[129]  H. Ljunggren,et al.  A mutant cell in which association of class I heavy and light chains is induced by viral peptides. , 1989, Cold Spring Harbor symposia on quantitative biology.

[130]  H. Mcdevitt,et al.  H–2-linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex , 1984, Nature.

[131]  A. Goldberg,et al.  A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[132]  W. Baumeister,et al.  The Proteasome: Paradigm Review of a Self-compartmentalizing Protease , 2022 .